PATENT CLAIM ANALYSIS

Application Number: 16161926
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-03
Patent Classification: ["544", "333000"]

Abstract:
Disclosed are benzamide derivatives useful in slowing the expansion of cancer cells.

Claim (Index 25):
A compound of formula: wherein X is selected from the group consisting of H, halo, \u2014C 1 -C 6  alkyl, aryl, \u2014C 3 -C 7  cycloalkyl, and -3-to 10-membered heterocycle; wherein Y is selected from the group consisting of H, \u2014C 1 -C 6  alkyl, \u2014C 3 -C 7  cycloalkyl, and \u2014C 1 -C 6  alkyl substituted with \u2014O\u2014(C 1 -C 6  alkyl); wherein Z is selected from the group consisting of: methyl, \u2014NH2, \u2014NHOH, and phenylene diamine group (II) of structure and wherein Q is selected from the group consisting of H, F and Cl;\n or a pharmaceutically acceptable salt or solvate thereof.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 97.0
- Lexical Diversity: 1.0
- Patent Class: 544.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14733952', '13380213', '13813813', '12295967', '10719896']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.800000455828109
- 35 USC 102 Novelty (BERT): 0.4631136817965471
- Combined Prediction Score: 0.7663117784249528
- Mean Citation Score: 201.57804600000003
- Max Citation Score: 229.9136
- Similarity Product: 221.6890288909912

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test